Decreasing risk of leukaemia during prolonged follow-up after mitobronitol therapy for polycythaemia vera.
D000368:Aged; D005500:Follow-Up Studies; D006801:Humans; D007938:Leukemia / Q000139:chemically induced*; D008353:Mannitol / Q000031:analogs & derivatives*; D008927:Mitobronitol / Q000009:adverse effects*; D011087:Polycythemia Vera / Q000188:drug therapy*; D012306:Risk
D008353:Mannitol; D008927:Mitobronitol